BNP Paribas Financial Markets
MURA

BNP Paribas Financial Markets’s Mural Oncology MURA Stock Holding History

BNP Paribas Financial Markets’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,376
Closed -$4.92K – 5884
2025
Q3 		$4.92K Sell
2,376
-10
-0.4% -$21 ﹤0.01% 5095
2025
Q2 		$5.89K Hold
2,386
– – ﹤0.01% 4939
2025
Q1 		$3.01K Sell
2,386
-41
-2% -$149 ﹤0.01% 4925
2024
Q4 		$7.82K Sell
2,427
-25,621
-91% -$90.3K ﹤0.01% 4876
2024
Q3 		$87.8K Sell
28,048
-68,686
-71% -$224K ﹤0.01% 3493
2024
Q2 		$304K Buy
96,734
+86,226
+821% +$318K ﹤0.01% 2917
2024
Q1 		$51.4K Buy
+10,508
New +$51K ﹤0.01% 3567

BNP Paribas Financial Markets's MURA Position: Q4 2025 in Review

BNP Paribas Financial Markets sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 2,376 shares — an estimated $4.92K sold.

BNP Paribas Financial Markets first reported a position in MURA in Q1 2024 and held it in 7 quarters. The position peaked at $304K in Q2 2024. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

  • BNP Paribas Financial Markets reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2,376 Mural Oncology shares in Q4 2025, an estimated $4.92K.
  • BNP Paribas Financial Markets first reported a position in Mural Oncology in Q1 2024 and held it in 7 quarters.
  • BNP Paribas Financial Markets's Mural Oncology position peaked at $304K in Q2 2024.
  • 0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2025, filed 10 Feb 2026.